A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH

by | Jun 2, 2025 | Clinical Trials | 0 comments

​ Conditions: Heterozygous Familial Hypercholesterolaemia

Interventions: Drug: AZD0780; Drug: Placebo

Sponsors: AstraZeneca

Not yet recruiting Conditions: Heterozygous Familial Hypercholesterolaemia
Interventions: Drug: AZD0780; Drug: Placebo
Sponsors: AstraZeneca
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *